ETA-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 3 49-3, 2001, Pages

  Podesser, Bruno K ^b   Siwik, Deborah A ^b   Eberli, Franz R ^b   Sam, Flora ^b   Ngoy, Soeun ^b   Lambert, Julie ^b   Ngo, Khahn ^b   Apstein, Carl S ^b   Colucci, Wilson S ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Endothelin; Left ventricle; Remodeling

Indexed keywords

ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; SITAXSENTAN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0034971752     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.3.h984     Document Type: Article

References (44)

1. Lung tissue hydrolysates: Studies of the optimum conditions for the spectrophotometric determination of hydroxyproline
2. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs
3. Collagen remodeling after myocardial infarction in the rat heart
4. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure
5. Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition
6. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
7. Myocardial endothelin. Does it play a role in myocardial failure?
8. Molecular and cellular mechanisms of myocardial failure
9. Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart
10. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions
11. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function
12. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction. Possible involvement of myocardial endothelin system in ventricular remodeling
13. 31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart
14. Effects of endothelins on collagen turnover in cardiac fibroblasts
15. Aggravation of left ventricular remodeling by a novel specific endothelin ET(A) antagonist EMD94246 in rats with experimental myocardial infarction
16. A receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload
17. 1B-adrenergic receptor mRNA in vascular smooth muscle cells
18. Endothelin receptors in cultured adult rat cardiac fibroblasts
19. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium
20. B receptors, and ECE and distribution of endothelin-1 in failing rat heart
21. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart
22. Mechanisms and models in heart failure: A combinatorial approach
23. Activation of matrix metalloproteinases in the failing human heart: Breaking the tie that binds
24. Characterization of endothelin-1 receptor subtypes in isolated human cardiomyocytes
25. A receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure
26. Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
27. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat
28. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats
29. Myocardial infarct size and ventricular function in rats
30. Coordinated upregulation of the cardiac endothelin system in a rat model of heart failure
31. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice
32. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice
33. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
34. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart
35. Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium of rats with heart failure
36. Role of endothelin-1 in myocardial failure
37. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy
38. Matrix metalloproteinase inhibition during the development of congestive heart failure: Effects on left ventricular dimensions and function
39. 1 expression in rat ventricular myocytes
40. 1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility
41. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
42. Inadequate collagen tethers in dilated cardiopathy
43. Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist
44. Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarction